Home > Press > Cell Guidance Systems use the ZetaView from Particle Metrix for exosome research and quality control
A CellGS scientist uses the Particle Metrix ZetaView for the study of exosomes |
Abstract:
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on how Cell Guidance Systems use the ZetaView® particle characterization system for exosome research and quality control.
Cell Guidance Systems (CellGS) provides innovative life science research tools and services. Their goal is to identify valuable innovations from research groups around the world and develop products that address unmet needs, providing new tools that expand the possibilities of life science research. The UK facility is located on the Babraham Science Park near Cambridge. Here, CellGS is developing novel tools and technologies for exosome research. In particular, they manufacture the Exo-spin range of exosome purification kits and TRIFic assay kits and are developing additional technologies to enable exosome research.
Exosomes are small lipid spheres around 40-150 nm in diameter that form within the cell. Exosomes contain and protect various RNA and protein cargos which are secreted into the blood and other bodily fluids. Exosomes are taken up by nearby and distant cells where their cargo can profoundly influence cellular activity. Consequently, there is interest in the potential of exosomes as vectors for gene therapy. In addition, many groups are now working on diagnostic products which can detect disease based on analysis of exosomes recovered from blood, urine, saliva and other body fluids.
For CellGS, developing new processes in research through to tight quality control procedures for production items requires the best in instrumentation. Speaking to this challenge, CellGS CEO, Michael Jones, describes their particle characterization needs and why they chose the Particle Metrix ZetaView® system to perform research into exosomes. “The ZetaView® enables our scientists to assess the quality of our exosome technologies and perform vital QC steps during manufacture. We selected ZetaView® after a full evaluation of competitive nanoparticle characterization systems. For us, the benefits in using the ZetaView® compared to other systems are its ease of use and throughput of sample measurement.”
The ZetaView® is a high performance integrated instrument for individual exosome particle tracking, classical micro-electrophoresis and Brownian motion. Auto-alignment and auto-focussing capabilities make the ZetaView® both fast and easy to use. A throughput of >20 samples per hour can readily be achieved. Highly resolved zeta potential and size histograms, as well as profiles, are routinely derived from thousands of particles. In addition, low concentrations of particles can be determined. The ZetaView® provides analysis certainty, leading to a better level of exosome characterization and enabling new discoveries in microvescicle and exosome research.
To receive more details about Particle Metrix and their family of particle characterization solutions, please contact Particle Metrix on +49 (0)2150-705679-0, visit the web site: www.particle-metrix.de.
####
About Particle Metrix GmbH
Particle Metrix GmbH develops and manufactures instruments to characterize particles with a family of innovative analytical systems. Nanoparticle Tracking Analysis (Optical Particle Tracking), 180° dynamic light scattering and streaming potential charge mapping are employed to deliver answers on dispersion stability, zeta potential, charge density, particle size, molecular weight and concentration. Scattered and fluorescent light as well as electrical streaming potential signals are detected and analyzed to deliver rapid analyses for a broad range of materials.
The products are made in Germany and are distributed worldwide. These are backed with certification under DIN EN ISO 9001. A fast growing publications list from users in research and industry testify to the reliability and confidence of the product line and Particle Metrix's competence to support them.
For more information, please click here
Contacts:
Particle-Metrix GmbH
Am Latumer See 11-13
40688 Meersbusch
Germany
T +49 (0)20150-705679-0
www.particle-metrix.de
Talking Science Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA UK
T +44(0)1799 521881
M +44(0)7843 012997
www.talking-science.com
Copyright © Particle Metrix GmbH
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||